Steris (STE) Tops Q4 EPS by 5c, Beats on Revenues
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $236.60 --0%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q4 EPS of $1.11, $0.05 better than the analyst estimate of $1.06. Revenue for the quarter came in at $681.2 million versus the consensus estimate of $673.61 million.
GUIDANCE:
Steris sees FY2018 EPS of $3.96-$4.09, versus the consensus of $3.72.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
- Legence Corp. (LGN) Misses Q2 EPS by 58c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
